omniture

iHuman Inc. Announces Third Quarter 2023 Unaudited Financial Results

2023-12-28 14:12 5042

BEIJING, Dec. 28, 2023 /PRNewswire/ -- iHuman Inc. (NYSE: IH) ("iHuman" or the "Company"), a leading provider of tech-powered, intellectual development products in China, today announced its unaudited financial results for the third quarter ended September 30, 2023.

Third Quarter 2023 Highlights

  • Revenues were RMB261.5 million (US$35.8 million), compared with RMB251.5 million in the same period last year.
  • Gross profit was RMB186.6 million (US$25.6 million), compared with RMB177.1 million in the same period last year.
  • Operating income was RMB40.4 million (US$5.5 million), compared with RMB38.5 million in the same period last year.
  • Adjusted operating income[1] was RMB42.9 million (US$5.9 million), compared with RMB42.5 million in the same period last year.
  • Net income was RMB51.9 million (US$7.1 million), compared with RMB39.5 million in the same period last year.
  • Adjusted net income[1] was RMB54.4 million (US$7.5 million), compared with RMB43.5 million in the same period last year.
  • Average total MAUs[2] reached a record-high of 25.36 million, a year-over-year increase of 22.9%.

Dr. Peng Dai, Director and Chief Executive Officer of iHuman, commented, "We are excited to announce another strong quarter of results with average total MAUs increasing an impressive 22.9% year-over-year to reach another record-high of 25.36 million, which I believe reflects our unwavering commitment to delivering exceptional experiences and value to our users."

"During the quarter, we focused squarely on strengthening our product portfolio in both domestic and international markets. Domestically, we further refined our industry-leading offerings with improvements to both content and functionality. We launched two additional exciting themes for iHumanpedia, "Earth Treasure Hunt" and "Animal Architects," which were specifically designed to nurture the scientific curiosity of children. As we continue to expand our content library, we are constantly developing innovative ways to engage users and enrich their experiences. For example, we hosted popular science competitions that encouraged participants to create science-themed short-form videos, among which the most outstanding entries would be featured on the iHumanpedia app. These initiatives as well as others we have rolled out all received enthusiastic feedback from users and are encouraging more active participation and contributing to a more vibrant community."

"Internationally, we enhanced the appeal of our products by rolling out popular seasonal themes that resonate with overseas users. For example, we launched a Halloween pack for Aha World which offered a wide selection of classic Halloween costumes and immersive, spooky experiences that were highly popular among younger audiences. Aha World has recently surged to rank among the top three most popular children's apps on Apple's app store in the U.S. These ongoing efforts to drive product excellence are increasingly earning us international recognition. Notably, we were awarded the prestigious w3 Gold Award in the Mobile Apps & Sites - Family & Kids category, for bekids Reading. With thousands of entries from across the globe annually, the w3 Awards is one of the most prestigious honors in digital design, marketing, media and technology that recognizes the industry's best across user experiences, content, and creativity. Winning the w3 Gold Award represents a substantial recognition of the high quality and innovative nature of our products and marks another significant milestone for us as a company specialized in child intellectual development."

"Our smart devices business also continued to make solid progress with the launch of the second generation of Logic Pal, an easy-to-operate device designed to facilitate early childhood word recognition, pronunciation, and cognitive growth through pluggable cards and interactive activities. To diversify our offerings, we have also launched Diandian Storyteller, a portable device that empowers children to enhance their storytelling abilities and expand their imagination."

"We are truly encouraged by the momentum across our entire portfolio and take great pride in our team's resolve and consistent execution. I am excited about the opportunities that lie ahead and the potential for our continuous growth and innovation," concluded Dr. Dai.

Ms. Vivien Weiwei Wang, Director and Chief Financial Officer of iHuman, added, "With an unwavering focus on long-term growth, we continue to invest in refining our product lineup while steadily expanding our overseas presence. Our dedication and relentless efforts to the business have enabled us to achieve another solid quarter. We once again recorded revenue growth on both an annual and sequential basis, marking our seventh consecutive profitable quarter. This remarkable achievement has further solidified our financial position, establishing a solid foundation for our future expansion."

"While we continue to advance our strategic priorities, we are also actively engaged in public initiatives that aim to inspire young minds and support their holistic development. Since the launch of bekids Coding, we have been enthusiastic participants in the Hour of Code, a global initiative that introduces tens of millions of students worldwide to computer science and programming through free coding tutorials and activities. In 2022, several elementary schools across the United States completed our Hour of Code challenge and shared their experiences on social media. This year, we are thrilled to participate in the Hour of Code initiative again, aiming to further inspire and engage children worldwide. Our participation in such events has strengthened our brand profile and influence internationally. As we move forward, our commitment to managing a strong portfolio of products and driving business growth will remain central to our strategy, ensuring sustainable development and creating more value for our shareholders."

Third Quarter 2023 Unaudited Financial Results

Revenues

Revenues were RMB261.5 million (US$35.8 million), an increase of 4.0% from RMB251.5 million in the same period last year, primarily driven by user expansion and enhanced user engagement.

Average total MAUs for the quarter were 25.36 million, an increase of 22.9% year-over-year from 20.63 million in the same period last year. The number of paying users[3] was 1.54 million.

Cost of Revenues

Cost of revenues was RMB74.9 million (US$10.3 million), maintaining approximately the same level of RMB74.4 million in the same period last year.

Gross Profit and Gross Margin

Gross profit was RMB186.6 million (US$25.6 million), an increase of 5.4% from RMB177.1 million in the same period last year. Gross margin was 71.4%, compared with 70.4% in the same period last year.

Operating Expenses

Total operating expenses were RMB146.2 million (US$20.0 million), an increase of 5.5% from RMB138.6 million in the same period last year.

Research and development expenses were RMB66.2 million (US$9.1 million), a decrease of 7.9% from RMB71.9 million in the same period last year, primarily due to payroll-related cost savings and decreased outsourcing expenses as a result of the continued optimization of our operational efficiency.

Sales and marketing expenses were RMB54.0 million (US$7.4 million), an increase of 29.6% from RMB41.7 million in the same period last year, primarily due to increased strategic spending on promotional activities.

General and administrative expenses were RMB26.1 million (US$3.6 million), compared with RMB25.0 million in the same period last year.

Operating Income

Operating income was RMB40.4 million (US$5.5 million), compared with RMB38.5 million in the same period last year.

Excluding share-based compensation expenses, adjusted operating income was RMB42.9 million (US$5.9 million), compared with RMB42.5 million in the same period last year.

Net Income

Net income was RMB51.9 million (US$7.1 million), an increase of 31.5% from RMB39.5 million in the same period last year.

Adjusted net income was RMB54.4 million (US$7.5 million), an increase of 25.1% from RMB43.5 million in the same period last year.

Basic and diluted net income per ADS were RMB0.98 (US$0.13) and RMB0.95 (US$0.13), respectively, compared with RMB0.74 and RMB0.73 in the same period last year. Each ADS represents five Class A ordinary shares of the Company.

Adjusted diluted net income per ADS was RMB0.99 (US$0.14), compared with RMB0.80 in the same period last year.

Deferred Revenue and Customer Advances

Deferred revenue and customer advances were RMB320.4 million (US$43.9 million) as of September 30, 2023, compared with RMB379.1 million as of December 31, 2022.

Cash, Cash Equivalents and Time Deposits

Cash, cash equivalents and time deposits were RMB1,174.2 million (US$160.9 million) as of September 30, 2023, compared with RMB1,050.0 million as of December 31, 2022.

[1] "Adjusted operating income" and "adjusted net income" exclude share-based compensation expenses. Please see "Non-GAAP Financial Measures" and "Unaudited Reconciliation of GAAP and non-GAAP Results" at the end of this press release.

[2] "Average total MAUs" refers to the monthly average of the sum of the MAUs of each of the Company's apps during a specific period, which is counted based on the number of unique mobile devices through which such app is accessed at least once in a given month, and duplicate access to different apps is not eliminated from the total MAUs calculation.

[3]  "Paying users" refers to users who paid subscription fees for premium content on any of the Company's apps during a specific period; a user who makes payments across different apps using the same registered account is counted as one paying user, and a user who makes payments for the same app multiple times in the same period is counted as one paying user.

Extension of Share Repurchase Program

Given its confidence in the Company's business prospects, the board of directors (the "Board") has authorized another extension of the Company's existing share repurchase program, as authorized in December 2021 and extended in December 2022, by twelve months through December 31, 2024. Pursuant to the extended share repurchase program, the Company's proposed repurchases may be made from time to time through open market transactions at prevailing market prices, in privately negotiated transactions, in block trades and/or through other legally permissible means, depending on the market conditions and in accordance with applicable rules and regulations. The timing and dollar amount of repurchase transactions will be subject to the Securities and Exchange Commission Rule 10b-18 and Rule 10b5-1 requirements. The Board will continue to review the extended share repurchase program periodically, and may authorize adjustments to its terms and size. The Company expects to continue to fund the repurchases under the extended share repurchase program with its existing cash balance.

Exchange Rate Information

The U.S. dollar (US$) amounts disclosed in this press release, except for those transaction amounts that were actually settled in U.S. dollars, are presented solely for the convenience of the reader. The conversion of Renminbi (RMB) into US$ in this press release is based on the exchange rate set forth in the H.10 statistical release of the Board of Governors of the Federal Reserve System as of September 29, 2023, which was RMB7.2960 to US$1.00. The percentages stated in this press release are calculated based on the RMB amounts.

Non-GAAP Financial Measures

iHuman considers and uses non-GAAP financial measures, such as adjusted operating income, adjusted net income and adjusted diluted net income per ADS, as supplemental metrics in reviewing and assessing its operating performance and formulating its business plan. The presentation of non-GAAP financial measures is not intended to be considered in isolation or as a substitute for the financial information prepared and presented in accordance with accounting principles generally accepted in the United States of America ("U.S. GAAP"). iHuman defines adjusted operating income, adjusted net income and adjusted diluted net income per ADS as operating income, net income and diluted net income per ADS excluding share-based compensation expenses, respectively. Adjusted operating income, adjusted net income and adjusted diluted net income per ADS enable iHuman's management to assess its operating results without considering the impact of share-based compensation expenses, which are non-cash charges. iHuman believes that these non-GAAP financial measures provide useful information to investors in understanding and evaluating the Company's current operating performance and prospects in the same manner as management does, if they so choose.

Non-GAAP financial measures are not defined under U.S. GAAP and are not presented in accordance with U.S. GAAP. Non-GAAP financial measures have limitations as analytical tools, which possibly do not reflect all items of expense that affect our operations. Share-based compensation expenses have been and may continue to be incurred in our business and are not reflected in the presentation of the non-GAAP financial measures. In addition, the non-GAAP financial measures iHuman uses may differ from the non-GAAP measures used by other companies, including peer companies, and therefore their comparability may be limited. The presentation of these non-GAAP financial measures is not intended to be considered in isolation from or as a substitute for the financial information prepared and presented in accordance with GAAP.

Safe Harbor Statement

This announcement contains forward-looking statements. These statements are made under the "safe harbor" provisions of the United States Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as "will," "expects," "anticipates," "future," "intends," "plans," "believes," "estimates"  and similar statements. Statements that are not historical facts, including statements about iHuman's beliefs and expectations, are forward-looking statements. Among other things, the description of the management's quotations in this announcement contains forward-looking statements. iHuman may also make written or oral forward-looking statements in its periodic reports to the U.S. Securities and Exchange Commission (the "SEC"), in its annual report to shareholders, in press releases and other written materials, and in oral statements made by its officers, directors or employees to third parties. Forward-looking statements involve inherent risks and uncertainties. A number of factors could cause actual results to differ materially from those contained in any forward-looking statement, including but not limited to the following: iHuman's growth strategies; its future business development, financial condition and results of operations; its ability to continue to attract and retain users, convert non-paying users into paying users and increase the spending of paying users, the trends in, and size of, the market in which iHuman operates; its expectations regarding demand for, and market acceptance of, its products and services; its expectations regarding its relationships with business partners; general economic and business conditions; regulatory environment; and assumptions underlying or related to any of the foregoing. Further information regarding these and other risks is included in iHuman's filings with the SEC. All information provided in this press release is as of the date of this press release, and iHuman does not undertake any obligation to update any forward-looking statement, except as required under applicable law.

About iHuman Inc.

iHuman Inc. is a leading provider of tech-powered, intellectual development products in China that is committed to making the child-upbringing experience easier for parents and transforming intellectual development into a fun journey for children. Benefiting from a deep legacy that combines over two decades of experience in the parenthood industry, superior original content, advanced high-tech innovation DNA and research & development capabilities with cutting-edge technologies, iHuman empowers parents with tools to make the child-upbringing experience more efficient. iHuman's unique, fun and interactive product offerings stimulate children's natural curiosity and exploration. The Company's comprehensive suite of innovative and high-quality products include self-directed apps, interactive content and smart devices that cover a broad variety of areas to develop children's abilities in speaking, critical thinking, independent reading and creativity, and foster their natural interest in traditional Chinese culture. Leveraging advanced technological capabilities, including 3D engines, AI/AR functionality, and big data analysis on children's behavior & psychology, iHuman believes it will continue to provide superior experience that is efficient and relieving for parents, and effective and fun for children, in China and all over the world, through its integrated suite of tech-powered, intellectual development products.

For more information about iHuman, please visit https://ir.ihuman.com/

For investor and media enquiries, please contact:

iHuman Inc.
Mr. Justin Zhang
Investor Relations Director
Phone: +86 10 5780-6606
E-mail: ir@ihuman.com 

Christensen
In China
Ms. Alice Li
Phone: +86-13381389369
E-mail: alice.li@christensencomms.com  

In the US
Ms. Linda Bergkamp
Phone: +1-480-614-3004
E-mail: linda.bergkamp@christensencomms.com  

 

 

iHuman Inc.

UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS

(Amounts in thousands of Renminbi ("RMB") and U.S. dollars ("US$")
except for number of shares, ADSs, per share and per ADS data)



December 31,


September 30,


September 30,


2022


2023


2023


RMB


RMB


US$







ASSETS






Current assets






Cash and cash equivalents 

1,049,999


1,037,751


142,236

Time deposits

-


136,416


18,697

Accounts receivable, net

79,614


69,381


9,509

Inventories, net

19,127


13,457


1,844

Amounts due from related parties

2,286


1,979


271

Prepayments and other current assets

102,765


83,999


11,513

Total current assets

1,253,791


1,342,983


184,070

Non-current assets






Property and equipment, net

9,205


6,530


895

Intangible assets, net

24,872


24,093


3,302

Operating lease right-of-use assets

12,782


4,056


556

Long-term investment

26,333


26,333


3,609

Other non-current assets

6,416


7,843


1,076

Total non-current assets

79,608


68,855


9,438

Total assets

1,333,399


1,411,838


193,508







LIABILITIES






Current liabilities






Accounts payable

24,206


16,235


2,225

Deferred revenue and customer advances

379,063


320,438


43,920

Amounts due to related parties

6,944


10,917


1,496

Accrued expenses and other current liabilities

144,717


131,722


18,054

Current operating lease liabilities

6,123


1,818


249

Total current liabilities

561,053


481,130


65,944

Non-current liabilities






Non-current operating lease liabilities

2,894


2,361


324

Total non-current liabilities

2,894


2,361


324

Total liabilities

563,947


483,491


66,268

SHAREHOLDERS' EQUITY






Ordinary shares (par value of US$0.0001 per share,
  700,000,000 Class A shares authorized as of December
  31, 2022 and September 30, 2023; 125,122,382 Class A
  shares issued and 121,722,467 outstanding as of
  December 31, 2022; 125,122,382 Class A shares issued
  and
119,698,967 outstanding as of September 30, 2023;
  200,000,000 Class B shares authorized, 144,000,000
  Class B ordinary shares issued and outstanding as of
  December 31, 2022 and September 30, 2023; 100,000,000
  shares (undesignated) authorized, nil shares
  (undesignated) issued and outstanding as of December 31,
  2022 and September 30, 2023)

185


185


25

Additional paid-in capital

1,079,099


1,086,502


148,917

Treasury stock

(7,123)


(16,665)


(2,284)

Statutory reserves

7,967


7,967


1,092

Accumulated other comprehensive income

10,497


23,895


3,275

Accumulated deficit

(321,173)


(173,537)


(23,785)

Total shareholders' equity

769,452


928,347


127,240

Total liabilities and shareholders' equity

1,333,399


1,411,838


193,508

 

 

 

iHuman Inc.

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(Amounts in thousands of Renminbi ("RMB") and U.S. dollars ("US$")
except for number of shares, ADSs, per share and per ADS data)



For the three months ended


For the nine months ended


September 30,


June 30,


September 30,


September 30,


September 30,


September 30,


September 30,


2022


2023


2023


2023


2022


2023


2023


RMB


RMB


RMB


US$


RMB


RMB


US$















Revenues

251,527


240,993


261,496


35,841


724,813


767,692


105,221

Cost of revenues

(74,422)


(70,160)


(74,871)


(10,262)


(214,636)


(224,667)


(30,793)















Gross profit

177,105


170,833


186,625


25,579


510,177


543,025


74,428















Operating expenses














Research and development expenses

(71,859)


(63,412)


(66,168)


(9,069)


(246,685)


(191,253)


(26,213)

Sales and marketing expenses

(41,669)


(40,564)


(53,994)


(7,400)


(111,105)


(134,993)


(18,502)

General and administrative expenses

(25,035)


(25,982)


(26,070)


(3,573)


(79,942)


(78,787)


(10,799)

Total operating expenses

(138,563)


(129,958)


(146,232)


(20,042)


(437,732)


(405,033)


(55,514)

Operating income

38,542


40,875


40,393


5,537


72,445


137,992


18,914

Other income, net

9,611


8,132


19,507


2,674


15,875


33,721


4,622

Income before income taxes

48,153


49,007


59,900


8,211


88,320


171,713


23,536

Income tax expenses

(8,675)


(6,933)


(7,984)


(1,094)


(13,934)


(24,077)


(3,300)

Net income

39,478


42,074


51,916


7,117


74,386


147,636


20,236















Net income per ADS:














   - Basic

0.74


0.80


0.98


0.13


1.39


2.79


0.38

   - Diluted

0.73


0.77


0.95


0.13


1.38


2.70


0.37















Weighted average number of ADSs:














   - Basic

53,240,710


52,804,594


52,747,426


52,747,426


53,341,120


52,834,352


52,834,352

   - Diluted

54,114,651


54,725,528


54,772,536


54,772,536


54,043,728


54,753,124


54,753,124















Total share-based compensation expenses included in:














Cost of revenues

77


70


67


9


180


235


32

Research and development expenses

2,045


1,142


1,160


159


3,813


2,940


403

Sales and marketing expenses

698


59


147


20


1,040


585


80

General and administrative expenses

1,187


1,160


1,105


151


2,963


3,557


488















 

 

 

iHuman Inc.

UNAUDITED RECONCILIATION OF GAAP AND NON-GAAP RESULTS

(Amounts in thousands of Renminbi ("RMB") and U.S. dollars ("US$")
except for number of shares, ADSs, per share and per ADS data)



For the three months ended


For the nine months ended


September 30,


June 30,


September 30,


September 30,


September 30,


September 30,


September 30,


2022


2023


2023


2023


2022


2023


2023


RMB


RMB


RMB


US$


RMB


RMB


US$















Operating income

38,542


40,875


40,393


5,537


72,445


137,992


18,914

Share-based compensation expenses

4,007


2,431


2,479


339


7,996


7,317


1,003

Adjusted operating income

42,549


43,306


42,872


5,876


80,441


145,309


19,917















Net income

39,478


42,074


51,916


7,117


74,386


147,636


20,236

Share-based compensation expenses

4,007


2,431


2,479


339


7,996


7,317


1,003

Adjusted net income

43,485


44,505


54,395


7,456


82,382


154,953


21,239















Diluted net income per ADS

0.73


0.77


0.95


0.13


1.38


2.70


0.37

Impact of non-GAAP adjustments

0.07


0.04


0.04


0.01


0.14


0.13


0.02

Adjusted diluted net income per ADS

0.80


0.81


0.99


0.14


1.52


2.83


0.39















Weighted average number of ADSs – diluted

54,114,651


54,725,528


54,772,536


54,772,536


54,043,728


54,753,124


54,753,124

Weighted average number of ADSs – adjusted

54,114,651


54,725,528


54,772,536


54,772,536


54,043,728


54,753,124


54,753,124

 

Source: iHuman Inc.
Related Stocks:
NYSE:IH
collection